Research Progress on 18F-Labeled Agents for Imaging of Myocardial Perfusion with Positron Emission Tomography. 2017

Tiantian Mou, and Xianzhong Zhang
Department of Nuclear Medicine, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China. mtt207@163.com.

Coronary artery disease (CAD) is the leading cause of death in the world. Myocardial perfusion imaging (MPI) plays a significant role in non-invasive diagnosis and prognosis of CAD. However, neither single-photon emission computed tomography nor positron emission tomography clinical MPI agents can absolutely satisfy the demands of clinical practice. In the past decades, tremendous developments happened in the field of 18F-labeled MPI tracers. This review summarizes the current state of 18F-labeled MPI tracers, basic research data of those tracers, and the future direction of MPI tracer research.

UI MeSH Term Description Entries
D011849 Radioactive Tracers Radioactive substances added in minute amounts to the reacting elements or compounds in a chemical process and traced through the process by appropriate detection methods, e.g., Geiger counter. Compounds containing tracers are often said to be tagged or labeled. (Hawley's Condensed Chemical Dictionary, 12th ed) Radioactive Tracer,Radionuclide Tracer,Radionuclide Tracers,Tracer, Radioactive,Tracer, Radionuclide,Tracers, Radioactive,Tracers, Radionuclide
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005462 Fluorine Radioisotopes Unstable isotopes of fluorine that decay or disintegrate emitting radiation. F atoms with atomic weights 17, 18, and 20-22 are radioactive fluorine isotopes. Radioisotopes, Fluorine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D049268 Positron-Emission Tomography An imaging technique using compounds labelled with short-lived positron-emitting radionuclides (such as carbon-11, nitrogen-13, oxygen-15 and fluorine-18) to measure cell metabolism. It has been useful in study of soft tissues such as CANCER; CARDIOVASCULAR SYSTEM; and brain. SINGLE-PHOTON EMISSION-COMPUTED TOMOGRAPHY is closely related to positron emission tomography, but uses isotopes with longer half-lives and resolution is lower. PET Imaging,PET Scan,Positron-Emission Tomography Imaging,Tomography, Positron-Emission,Imaging, PET,Imaging, Positron-Emission Tomography,PET Imagings,PET Scans,Positron Emission Tomography,Positron Emission Tomography Imaging,Positron-Emission Tomography Imagings,Scan, PET,Tomography Imaging, Positron-Emission,Tomography, Positron Emission
D055414 Myocardial Perfusion Imaging The creation and display of functional images showing where the blood is flowing into the MYOCARDIUM by following over time the distribution of tracers injected into the blood stream. Myocardial Scintigraphy,Scintigraphy, Myocardial,Imaging, Myocardial Perfusion,Perfusion Imaging, Myocardial
D019275 Radiopharmaceuticals Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) Radiopharmaceutical

Related Publications

Tiantian Mou, and Xianzhong Zhang
November 2020, European journal of medicinal chemistry,
Tiantian Mou, and Xianzhong Zhang
November 2017, Nuclear medicine and biology,
Tiantian Mou, and Xianzhong Zhang
January 2020, Methodist DeBakey cardiovascular journal,
Tiantian Mou, and Xianzhong Zhang
October 2021, Journal of medicinal chemistry,
Tiantian Mou, and Xianzhong Zhang
March 2021, European journal of medicinal chemistry,
Tiantian Mou, and Xianzhong Zhang
March 1998, Nihon rinsho. Japanese journal of clinical medicine,
Tiantian Mou, and Xianzhong Zhang
February 2024, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
Tiantian Mou, and Xianzhong Zhang
June 2025, Molecular pharmaceutics,
Tiantian Mou, and Xianzhong Zhang
July 1994, Nihon rinsho. Japanese journal of clinical medicine,
Tiantian Mou, and Xianzhong Zhang
July 1991, American heart journal,
Copied contents to your clipboard!